Covis Pharma Announces FDA’s Decision to Grant Public Hearing for Only FDA-Approved Treatment to Reduce Preterm Birth in Indicated Patients
August 19, 2021 13:11 ET
|
Covis Pharma
ZUG, Switzerland, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Covis Group S.à r.l. (“Covis”) announced today that the U.S. Food and Drug Administration (FDA) has granted a public hearing to discuss Makena,...